Bellerophon Therapeutics has reached an agreement with the U.S. Food and Drug Administration (FDA) setting the design of…
Articles by Marisa Wexler, MS
Use of Bellerophon Therapeutics’ INOpulse device — which provides nitric…
Vitamin C deficiency can cause pulmonary arterial hypertension (PAH), a new case report suggests, highlighting the need to test…
Treatment with sotatercept (ACE-011) eased heart strain and improved exercise capacity in individuals with…
Levels of a circular RNA molecule in the blood could help diagnose and predict the clinical outcomes of those with…
Over the last year, Pulmonary Hypertension News has brought you the latest news about groundbreaking discoveries, treatment developments, clinical trials, and…
TriAxia Health is partnering with three academic medical centers to build a large database aiming for a better understanding…
Cardiopulmonary exercise testing can improve the ability of an algorithm to identify systemic sclerosis patients who have pulmonary arterial…
Having pulmonary hypertension (PH) does not affect the benefits of lung volume reduction surgery for people with emphysema, who…
INOpulse can improve physical activity in people with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and helps them to…
Adcirca (tadalafil) helped to improve survival in dogs with pulmonary hypertension (PH), a new study suggests. Knowing the…
Altavant Sciences presented its patient-centered approach to drug development, which informed the design of an ongoing Phase 2 study,…